View Document Preview and Link
Document Date: 2013-02-05 21:22:52 Open Document File Size: 245,90 KB Share Result on Facebook
City Birmingham / Cambridge / Melville / / Company Huybrechts SA / Ferro / Ford / MNH 15157 Diagnostics / Wolters Kluwer / / Continent America / Europe / / Country United Kingdom / China / / / Facility Addenbrooke’s Hospital / Hall FC / / IndustryTerm clinical applications / arterial media / invaluable tool / treatment of cardiorenal disease / clinical tool / Arterial media calcification / / MedicalCondition JE / peripheral arterial disease / arteriosclerosis / early chronic kidney disease / arterial hypertension / chronic renal failure / rheumatoid arthritis / proteinuria and arterial stiffness / endstage renal disease / chronic kidney disease / obesity / cardiorenal disease / end-stage renal disease / microvascular disease / inflammatory diseases / arrhythmia / proteinuria / end-stage renal failure / central obesity / Cardiac hypertrophy / hypertension / atherosclerosis / kidney disease / left ventricular hypertrophy / endothelial dysfunction / ESRD / stroke / contraction / aortic stenosis / chronic renal insufficiency cohort study / cardiovascular disease / predialysis chronic kidney disease / chronic proteinuric kidney disease / diseases / antitumor necrosis / atrial fibrillation / Inflammation / chronic renal impairment / early-stage chronic kidney disease / carotid sinus syndrome / fibrosis / end-stage kidney disease / / NaturalFeature Savage MT / / Organization European Society of Hypertension / Addenbrooke’s Hospital / ESC Task Force / Clinical Pharmacology Unit / Department of Clinical Pharmacology / European Society of Cardiology Guidelines for the Management of Hypertension / / Person Clin Sci / Van Bortel / Arch Pathol / Laurie A. Tomlinson / / / Position Stewart PM / et al / field forward / Clinical Lecturer / major driver / / Product spironolactone / / PublishedMedium Lippincott Williams & Wilkins / / Technology alpha / AV / MRI / / URL www.co-nephrolhypertens.com / / SocialTag